Global Gabapentin Market Size & Outlook, 2025-2030

The global gabapentin market size was estimated at USD 2,254.2 million in 2024 and is projected to reach USD 3,070.4 million by 2030, growing at a CAGR of 5.2% from 2025 to 2030.
Revenue, 2024 (US$M)
$2,254.2
Forecast, 2030 (US$M)
$3,070.4
CAGR, 2025 - 2030
5.2%
Report Coverage
Worldwide

Global gabapentin market highlights

  • The global gabapentin market generated a revenue of USD 2,254.2 million in 2024 and is expected to reach USD 3,070.4 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 5.2% by 2030.
  • In terms of segment, capsule accounted for a revenue of USD 1,332.6 million in 2024.
  • Tablet is the most lucrative dosage form segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, Italy is expected to register the highest CAGR from 2025 to 2030.

Global data book summary

Market revenue in 2024USD 2,254.2 million
Market revenue in 2030USD 3,070.4 million
Growth rate5.2% (CAGR from 2025 to 2030)
Largest segmentCapsule
Fastest growing segmentTablet
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTablet, Capsule, Oral Solution

Other key industry trends

  • In terms of revenue, the North America accounted for 33.7% of the global gabapentin market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Italy is the fastest growing regional market and is projected to reach USD 79.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gabapentin Market Companies

Name Profile # Employees HQ Website
Ascendis Pharma View profile 501-1000 Palo Alto, California, United States, North America http://ascendispharma.com
Assertio Holdings Inc View profile 30 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 https://www.assertiotx.com
Glenmark Pharmaceuticals View profile 10001+ Andheri, Maharashtra, India, Asia http://www.glenmarkpharma.com
Apotex Inc. View profile 10001+ Toronto, Ontario, Canada, North America http://www.apotex.com
Amneal Pharmaceuticals View profile 5001-10000 Bridgewater, New Jersey, United States, North America http://amneal.com/
Arbor Pharmaceuticals View profile 501-1000 Atlanta, Georgia, United States, North America http://www.arborpharma.com
Zydus Lifesciences View profile 10001+ Ahmedabad, Gujarat, India, Asia https://zyduslife.com/
Sun Pharmaceutical Industries View profile 10001+ Mumbai, Maharashtra, India, Asia http://www.sunpharma.com
Aurobindo Pharma View profile 10001+ Hyderabad, Andhra Pradesh, India, Asia http://aurobindo.com
Cipla Ltd DR View profile 38955 Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 https://www.cipla.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

Global gabapentin market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gabapentin market will help companies and investors design strategic landscapes.


Capsule was the largest segment with a revenue share of 59.12% in 2024. Horizon Databook has segmented the Global gabapentin market based on tablet, capsule, oral solution covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Gabapentin Dosage Form Outlook (Revenue, USD Million, 2018-2030)
    • Tablet
    • Oral Solution
    • Capsule
  • Global Gabapentin Type Outlook (Revenue, USD Million, 2018-2030)
    • Branded
    • Generic
  • Global Gabapentin Application Outlook (Revenue, USD Million, 2018-2030)
    • Neuropathic Pain
    • Restless Legs Syndrome
    • Others
    • Epilepsy
  • Global Gabapentin Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
    • Retail Pharmacy
    • Online Pharmacy
    • Hospital Pharmacy

Reasons to subscribe to Global gabapentin market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global gabapentin market databook

  • Our clientele includes a mix of gabapentin market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global gabapentin market , including forecasts for subscribers. This global databook contains high-level insights into Global gabapentin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global gabapentin market size, by regions, 2018-2030 (US$M)

Top 10 countries: Gabapentin market size, 2024 (US$M)

Global gabapentin market share, by type, 2024 & 2030 (%, US$M)

Gabapentin market: Opportunity assessment by country

Global gabapentin market, by region, 2024 (US$M)

Global gabapentin market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online